Changes in the MRI brain picture associated with newly diagnosed asymptomatic arterial hypertension

Cover Page


Cite item

Full Text

Abstract

ntroduction. Arterial hypertension (AH) is the major modified risk factor for brain injury. Clarification of the brain changes and the mechanisms of their development during the asymptomatic stage will ensure better results in the prevention of AH complications.
Objective. The study purpose was to evaluate specific changes in the brain MRI picture, associated with AH of varying severity.
Materials and methods. The study involved 82 patients with newly diagnosed asymptomatic AH, aged 45–59 years. The patients underwent MRI of the brain (T1 and T2 weighted images, FLAIR, diffusion weighted imaging with calculation of an apparent diffusion coefficient (ADC) map). We evaluated the localization and severity of white matter hyperintensity (WMH), lacunar infarcts, and dilated perivascular spaces as well as the white matter microstructure based on ADC in a visually intact white matter in areas of its potential vulnerability.
Results. The earliest and most typical change is the formation of hyperintensity lesions in the juxtacortical areas of the frontal lobes. AH worsening is associated with an increase in the number of hyperintensity lesions from the frontal to occipital areas of the white brain matter and from the surface to deep brain regions as well as microstructural changes in the intact white matter in potential vulnerability areas.
Conclusion. The observed high correlations between WMH and dilated semioval perivascular spaces and increased diffusion in the intact white matter as well as the absence of similar correlations for lacunar infarcts suggest that the pathophysiological basis of early brain changes in AH is increased vascular permeability, but not ischemia. The factors of a high risk of clinical symptoms include lesion extension to the posterior brain structures, multiple foci of hyperintensity in the periventricular white matter of the frontal lobes, and an increasing number of lacunar infarcts. These findings are significant for evaluating potential risk of clinical symptoms and for understanding the mechanisms of early brain injury in AH.

About the authors

Larisa A. Dobrynina

Research Center of Neurology

Author for correspondence.
Email: Dobrla@mail.ru
ORCID iD: 0000-0001-9929-2725

D. Sci. (Med.), Head, 3rd Neurology department

Russian Federation, Moscow

Elena V. Gnedovskaya

Research Center of Neurology

Email: dobrla@mail.ru
Russian Federation, Moscow

Anastasiya N. Sergeeva

Research Center of Neurology

Email: Dobrla@mail.ru
Russian Federation, Moscow

Marina V. Krotenkova

Research Center of Neurology

Email: Dobrla@mail.ru
ORCID iD: 0000-0003-3820-4554

D. Sci. (Med.), Head, Neuroradiology department

Russian Federation, 125367 Moscow, Volokolamskoye shosse, 80

Мikhail A. Piradov

Research Center of Neurology

Email: Dobrla@mail.ru
ORCID iD: 0000-0002-6338-0392

D. Sci. (Med), Prof., Full Member of RAS, Director, Research Center of Neurology, Moscow, Russia; Head, Division of diseases of the nervous system

Russian Federation, 125367 Moscow, Volokolamskoye shosse, 80

References

  1. Ганнушкина И.В. Лебедева Н.В. Гипертоническая энцефалопатия. М.: Медицина, 1987.
  2. Гулевская Т.С., Людковская И.Г. Особенности изменений сосудов коры и белого вещества полушарий головного мозга при артериальной гипертонии. Журн. невропат. и психиатрии им. С.С.Корсакова 1985; 7: 979–989.
  3. Добрынина Л.А., Коновалов Р.Н., Кремнева Е.И., Кадыков А.С. МРТ в оценке двигательного восстановления больных с хроническими супратенториальными инфарктами. Анн. клинич. и эксперим. неврол. 2012; 6 (2): 4–10.
  4. Оганов Р.Г., Тимофеева Т.Н., Колтунов И.Е. и др. Эпидемиология артериальной гипертонии в России. Результаты федерального мониторинга 2003–2010 гг. Кардиоваскулярная терапия и профилактика 2011; 10 (1): 9–13.
  5. Российское медицинское общество по артериальной гипертонии. Всероссийское научное общество кардиологов. Диагностика и лечение артериальной гипертонии. Российские рекомендации (четвертый пересмотр). М., 2010.
  6. Чазова И.Е., Ощепкова Е.В. Итоги реализации Федеральной целевой программы по профилактике и лечению артериальной гипертензии в России 2002–2012 гг. Вестник РАМН. 2013; 2; 4–11.
  7. Шальнова С.А. Эпидемиология артериальной гипертензии в России: портрет больного. Артериальная гипертензия (клинический семинар) 2008; 2 (2): 5–10.
  8. Abraham H.M., Wolfson L., Moscufo N. et al. Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons. J Cereb Blood Flow Metab. 2016; 36 (1): 132–142. PMID: 26036933 doi: 10.1038/jcbfm.2015.121.
  9. Amarenco P., Bogousslavsky J., Caplan L.R. et al. The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013; 36 (1): 1–5. PMID: 23899749 doi: 10.1159/000352050.
  10. Bolandzadeh N., Davis J.C., Tam R. et al. The association between cognitive function and white matter lesion location in older adults: a systematic review. BMC Neurol. 2012; 12: 126. PMID: 23110387 doi: 10.1186/1471-2377-12-126.
  11. Debette S., Markus H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010; 341: c3666. PMID: 20660506 doi: 10.1136/bmj.c3666.
  12. de Groot M., Verhaaren B.F., de Boer R. et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke. 2013; 44 (4): 1037–1042. PMID: 23429507 doi: 10.1161/STROKEAHA.112.680223.
  13. De Laat K.F., Tuladhar A.M., van Norden A.G. et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2011; 134 (Pt 1): 73–83. PMID: 21156660 doi: 10.1093/brain/awq343.
  14. De Leeuw F.E., de Groot J.C., Oudkerk M. et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002; 125 (Pt 4): 765–772. PMID: 11912110
  15. Dufouil C., de Kersaint-Gilly A., Besançon V. et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.Neurology. 2001; 56 (7): 921–926. PMID: 11294930
  16. Filomena J., Riba-Liena I., Vinyoles E. et al. Short-Term Blood Pressure Variability Relates to the Presence of Subclinical Brain Small Vessel Disease in Primary Hypertension. Hypertension. 2015; 66 (3):634–640; discussion 445. PMID: 26101344 doi: 10.1161/HYPERTENSIONAHA.115.05440
  17. Firbank M.J., Wiseman R.M., Burton E.J. et al. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol. 2007; 254 (6): 713–721. PMID: 17446997 doi: 10.1007/s00415-006-0238-4
  18. Friedman J.I., Tang C.Y., de Haas H.J. et al. Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients. JACC Cardiovasc Imaging. 2014; 7 (10):1039–1053 PMID: 25323165 doi: 10.1016/j.jcmg.2014.06.014.
  19. Gons R.A., de Laat K.F., van Norden A.G. et al. Hypertension and cerebral diffusion tensor imaging in small vessel disease. Stroke. 2010; 41 (12): 2801–2806. PMID: 21030696 doi: 10.1161/STROKEAHA.110.597237.
  20. Gouw A.A., Seewann A., van der Flier W.M. et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011; 82 (2): 126–135.PMID: 20935330 doi: 10.1136/jnnp.2009.204685.
  21. Gouw A.A., van der Flier W.M., Fazekas F. et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period the leukoaraiosis and disability study. Stroke. 2008; 39 (5): 1414–1420. PMID: 18323505 doi: 10.1161/STROKEAHA.107.498535
  22. Hannesdottir K., Nitkunan A., Charlton R.A. et al. Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand. 2009; 119 (4): 261–268. PMID: 18798828 doi: 10.1111/j.1600-0404.2008.01098.x.
  23. Johansson B., Martinsson L. b-Adrenoreceptor antagonists and the dysfunction of the blood-brain barrier induced by adrenaline. Brain Res. 1980; 181 (1): 219–222. PMID: 6101306
  24. Johansson B. Pharmacological modification of hypertensive bloodbrain barrier opening. ActaPharmacol. 1981; 48: 242–247.
  25. Ki Woong Kim, MacFall J.R., Payne M.E. Classification of white matter lesions on magnetic resonance imaging in the elderly. Biol. Psychiatry. 2008; 64 (4): 273–280. PMID: 18471801 doi: 10.1016/j.biopsych.2008.03.024
  26. LADIS Study Group. 2001–2011: a decade of the LADIS (LeukoaraiosisAndDISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis. 2011; 32 (6): 577–588. PMID: 22277351
  27. Lawes C.M., Vander Hoorn S., Rodgers A., International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371 (9623): 1513–1518. PMID: 18456100 doi: 10.1016/S0140-6736(08)60655-8
  28. Lawrence A.J., Patel B., Morris R.G. et al. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George’s cognition and neuroimaging in stroke (SCANS) study. PLoS One. 2013; 8 (4): e61014. PMID: 23613774 doi: 10.1371/journal.pone.0061014.
  29. Lim S.S., Vos T., Flaxman A.D. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012; 380 (9859): 2224–2260. PMID: 23245609 doi: 10.1016/S0140-6736(12)61766-8
  30. Mac Kenzie E.T., Strandgaard S., Graham D.I. et al. Effects of acutely induced hypertensionin cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. – Circulat. Res. 1976; 39 (1): 33–41. PMID: 1277403
  31. Mancia G., Fagard R., Narkiewicz K. et al. ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension. 2013, 31 (7): 1281–1357. PMID: 23817082 doi: 10.1097/01.hjh.0000431740.32696.cc
  32. Meissner A. Hypertension and the Brain: A Risk Factor for More Than Heart Disease. Cerebrovasc Dis. 2016; 42 (3–4): 255–262. PMID: 27173592 doi: 10.1159/000446082
  33. Pantoni L., Fierini F., Poggesi A.; LADIS Study Group. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions. Geriatr Gerontol Int. 2015; 15 Suppl 1: 10–16. PMID: 26671152 doi: 10.1111/ggi.12665
  34. Roger V.L., Go A.S., Lloyd-Jones D.M. et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012; 125 (1): e2–e220. PMID: 22179539 DOI: 10.1161/ CIR.0b013e31823ac046
  35. Schmidt R., Ropele S., Ferro J. et al. Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study. Stroke. 2010 May; 41 (5): e402–е408. PMID: 20203319 doi: 10.1161/STROKEAHA.109.576629
  36. Van Dijk E.J., Breteler M.M., Schmidt R. et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension. 2004; 44 (5): 625–630. PMID: 15466662 doi: 10.1161/01.HYP.0000145857.98904.20
  37. Van Dijk E.J., Prins N.D., Vrooman H.A. et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke. 2008; 39 (10): 2712–2719. PMID: 18635849 doi: 10.1161/STROKEAHA.107.513176
  38. Verhaaren B.F., Vernooij M.W., de Boer R. et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013; 61 (6): 1354–1359. PMID: 23529163 doi: 10.1161/HYPERTENSIONAHA.111.00430
  39. Wardlaw J.M., Smith E.E, Biessels G.J. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12 (8): 822–838. PMID: 23867200 doi: 10.1016/S1474-4422(13)70124-8

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Dobrynina L.A., Gnedovskaya E.V., Sergeeva A.N., Krotenkova M.V., Piradov M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies